Venaxis (Nasdaq: APPY) 72.3% LOWER; announced the United States Food and Drug Administration (“FDA”) has determined that the APPY1 Test does not meet the criteria
previous post
next post
Venaxis (Nasdaq: APPY) 72.3% LOWER; announced the United States Food and Drug Administration (“FDA”) has determined that the APPY1 Test does not meet the criteria